FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Kite Therapy Approved for Mantle Cell Lymphoma

FDA grants Kite accelerated approval for Tecartus (brexucabtagene autoleucel) for treating adult patients with relapsed or refractory mantle cell lymp...

Human Drugs

Surgical Insufflator/Smoke Evacuator Cleared

FDA clears a Palliare 510(k) for its EVA15 insufflator and smoke evacuation system.

Human Drugs

Taro Pays $205 Million in Generic Price Fixing Settlement

Taro Pharmaceuticals agrees to pay $205 million in criminal fines to resolve charges of conspiring to fix prices for generic drugs.

Human Drugs

AstraZenecas Breztri Approved for COPD

FDA approves an AstraZeneca NDA for Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for the maintenance treatment of patients with ...

Human Drugs

MyoKardia Gets Breakthrough Status for Mavacamten

FDA grants MyoKardia a breakthrough therapy designation for mavacamten, an oral, allosteric modulator of cardiac myosin for treating symptomatic, obst...

Medical Devices

Many Recalls in Healthcare Deployment of Devices: Report

Internet of Things (IoT) security firm Ordr says many IoT medical devices have been subject to FDA recall as defective or risky.

Medical Devices

Senate Bill on FDA Seizing/Detroying Counterfeit Devices

U.S. senators Mike Enzi (R-WY) and Maggie Hassan (D-NH) introduce legislation that would help protect patients from counterfeit medical products that ...

Federal Register

Info Collection on ICH Good Clinical Practice Guide

Federal Register notice: FDA sends to OMB an information collection extension for an International Council for Harmonization good clinical practice gu...

Federal Register

Pediatric Advisory Panel to Discuss Safety Reviews

Federal Register notice: FDA announces a 9/15 Pediatric Advisory Committee meeting to discuss pediatric-focused safety reviews.

Human Drugs

FDA Proposes Right to Try Summary Rule

FDA proposes a rule establishing deadlines and contents requirements for the annual summary to be submitted by drug sponsors and manufacturers under t...